Related Experiment Video
Updated: Nov 15, 2025
07:40
Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
1.4K
[COVID-19 and myocardial injury]
Sara Schukraft1, Serban Puricel1, Sébastien Doll2
1Service de cardiologie, Hôpital et Université de Fribourg, 1752 Villars-sur-Glâne.
Revue Medicale Suisse
|March 3, 2021
Summary
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) impacts the heart, causing inflammation and myocardial injury. This article details the mechanisms and clinical outcomes of cardiac involvement in COVID-19 patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Pathophysiology
Background:
- The novel coronavirus, SARS-CoV-2, has demonstrated significant multi-organ effects beyond the respiratory system.
- Cardiovascular complications are increasingly recognized as a major concern in patients with COVID-19.
Purpose of the Study:
- To elucidate the pathophysiological mechanisms linking SARS-CoV-2 infection to cardiovascular damage.
- To outline the clinical manifestations and implications of myocardial injury in the context of COVID-19.
Main Methods:
- Review of current scientific literature on SARS-CoV-2 and cardiovascular effects.
- Analysis of proposed direct viral invasion and indirect inflammatory pathways.
- Synthesis of clinical data regarding myocardial injury markers and outcomes.
Main Results:
- SARS-CoV-2 triggers a significant proinflammatory response, contributing to cardiovascular complications.
- Both direct viral attack on cardiomyocytes and indirect inflammatory processes lead to myocardial injury.
- Clinical implications include arrhythmias, heart failure, and increased risk of adverse cardiac events.
Conclusions:
- Understanding the mechanisms of SARS-CoV-2-induced myocardial injury is crucial for patient management.
- Early recognition and intervention for cardiac complications can improve outcomes in COVID-19 patients.
- Further research is needed to fully delineate the long-term cardiovascular sequelae of SARS-CoV-2 infection.
Related Concept Videos
01:14Myocarditis III: Medical Management
66
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
66
01:21Myocarditis I: Introduction
153
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
153
01:27Myocarditis II: Clinical Features and Diagnostic Tests
96
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
96
01:22Myocarditis IV: Nursing Management
99
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
99
01:30Acute Coronary Syndrome I: Introduction
281
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
281
01:28Acute Coronary Syndrome IV: Interprofessional Care
94
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
94